Liraglutide in PCOS (LIPOS) Study: Evaluation of the Efficacy of Liraglutide on Menstrual Cyclicity in Women with PCOS - a prospective randomised double-blind placebo-controlled study

Trial Profile

Liraglutide in PCOS (LIPOS) Study: Evaluation of the Efficacy of Liraglutide on Menstrual Cyclicity in Women with PCOS - a prospective randomised double-blind placebo-controlled study

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 08 Jun 2016

At a glance

  • Drugs Liraglutide (Primary) ; Metformin
  • Indications Polycystic ovary syndrome
  • Focus Therapeutic Use
  • Acronyms LIPOS
  • Most Recent Events

    • 19 Oct 2015 Accrual to date is 175% according to United Kingdom Clinical Research Network record.
    • 19 Oct 2015 Planned End Date changed from 30 Jun 2015 to 31 Jul 2015 as reported by United Kingdom Clinical Research Network record.
    • 19 Oct 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top